Matt Mandeville
Senior Business Development Manager BrainXell
Seminars
Wednesday 3rd June 2026
Modeling ALS & FTD with Human iPSC-derived Neurons & glia
2:00 pm
- BrainXell is a leading provider of hiPSC-derived neurons and glia, working with over 75% of the world’s largest pharmaceutical companies
- Review our comprehensive off-the-shelf portfolio, highlighting BrainXell’s new oligodendrocyte progenitor cells (OPCs), and ALS disease models
- Robust, scalable manufacturing processes generate billions of cells, and flexible custom workflows deliver the same highquality cell types from any customer-supplied iPSC line
- Assay services integrate functional and molecular readouts to support target validation, drug screening, disease modeling and accelerated discovery through direct scientific collaboration
